Literature DB >> 24416544

Whole brain radiotherapy: Consequences for personalized medicine.

Tomáš Kazda1, Petr Pospíšil1, Hana Doleželová1, Radim Jančálek2, Pavel Slampa1.   

Abstract

Several studies focusing on brain irradiation are in progress. Reflecting updates of relevant outcomes in palliative treatment of patients suffering from brain metastases, the primary objective of these studies is the evaluation of neurocognitive function and quality of life. Improvements of technology in radiation oncology allows us to spare the hippocampal region while appropriately irradiating other parts of brain tissue. Irradiation of the hippocampus region is likely to lead to manifestations of adverse events with a subsequent impact on patient's quality of life, which is in fact an improper approach in palliative medicine. Ongoing studies evaluate results of hippocampus avoiding radiotherapy compared to standard whole brain radiotherapy. Incorporation of neurocognitive function assessment may result in the confirmation of superiority of sparing the region of hippocampus and thus change current style of providing brain irradiation.

Entities:  

Keywords:  Brain metastases; Decision-making; Personalized medicine; Whole brain radiotherapy

Year:  2013        PMID: 24416544      PMCID: PMC3863163          DOI: 10.1016/j.rpor.2013.03.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  32 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Authors:  Hidefumi Aoyama; Masao Tago; Norio Kato; Tatsuya Toyoda; Masahiro Kenjyo; Saeko Hirota; Hiroki Shioura; Taisuke Inomata; Etsuo Kunieda; Kazushige Hayakawa; Keiichi Nakagawa; Gen Kobashi; Hiroki Shirato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-01       Impact factor: 7.038

3.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

Authors:  Paul W Sperduto; Brian Berkey; Laurie E Gaspar; Minesh Mehta; Walter Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

4.  Comparison of individual and composite field analysis using array detector for Intensity Modulated Radiotherapy dose verification.

Authors:  Sathiyan Saminathan; Varatharaj Chandraraj; C H Sridhar; Ravikumar Manickam
Journal:  Rep Pract Oncol Radiother       Date:  2012-05-19

5.  Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933.

Authors:  Vinai Gondi; Wolfgang A Tome; James Marsh; Aaron Struck; Amol Ghia; Julius V Turian; Søren M Bentzen; John S Kuo; Deepak Khuntia; Minesh P Mehta
Journal:  Radiother Oncol       Date:  2010-04-12       Impact factor: 6.280

6.  Refining endpoints in brain tumor clinical trials.

Authors:  Christina A Meyers; Edwin P Rock; Howard A Fine
Journal:  J Neurooncol       Date:  2012-03-27       Impact factor: 4.130

Review 7.  Treatment of brain metastases: review of phase III randomized controlled trials.

Authors:  Silvia Scoccianti; Umberto Ricardi
Journal:  Radiother Oncol       Date:  2011-10-11       Impact factor: 6.280

8.  Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).

Authors:  Tatjana Seute; Pieter Leffers; Guul P M ten Velde; Albert Twijnstra
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

9.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

10.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07
View more
  6 in total

1.  Tolerability and toxicity of prophylactic cranial irradiation in patients with non-small cell lung cancer - Results of a phase II study (with estimation of hematological toxicity, pituitary function and magnetic resonance spectra changes).

Authors:  Marzena Gawkowska-Suwińska; Sławomir Blamek; Alicja Heyda; Lukasz Boguszewicz; Anna Cichoń; Lukasz Zarudzki; Elżbieta Nowicka; Katarzyna Behrendt; Beata Smolska-Ciszewska; Grzegorz Plewicki; Aleksander Zajusz; Rafał Tarnawski
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-17

2.  Brain metastases from stomach cancer - The role of different treatment modalities and efficacy of palliative radiotherapy.

Authors:  Malgorzata Kraszkiewicz; Jerzy Wydmanski
Journal:  Rep Pract Oncol Radiother       Date:  2014-08-28

3.  External-Beam Radiotherapy Alone Management of Primary CNS Lymphoplasmacytic Lymphoma: A Vietnamese Case Report and Literature Review.

Authors:  Dang Nguyen Van; Nghia Duong Van; Quang Le Van; Tung Ngo Thanh; To Ta Van
Journal:  J Blood Med       Date:  2021-08-21

4.  Hippocampal proton MR spectroscopy as a novel approach in the assessment of radiation injury and the correlation to neurocognitive function impairment: initial experiences.

Authors:  Petr Pospisil; Tomas Kazda; Martin Bulik; Marie Dobiaskova; Petr Burkon; Ludmila Hynkova; Pavel Slampa; Radim Jancalek
Journal:  Radiat Oncol       Date:  2015-10-17       Impact factor: 3.481

Review 5.  Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report.

Authors:  Min-Joo Ahn; Kanghan Lee; Kyung Hwa Lee; Jin Woong Kim; In-Young Kim; Woo Kyun Bae
Journal:  BMC Cancer       Date:  2018-02-12       Impact factor: 4.430

6.  Palliative whole-brain radiotherapy and health- related quality of life for patients with brain metastasis in cancer.

Authors:  Ying Gao; Fei Gao; Jin-Lu Ma; Dong-Li Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-21       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.